Bibliographie (2530)
New WHO Online Course: Initial approach to the acutely ill patient with COVID-19.
lundi, 10 mai 2021 04:44 Écrit par Zouhair SouissiClinical management of patients with COVID-19: Initial approach to the acutely ill patient – World Health Organization
The post New WHO Online Course: Initial approach to the acutely ill patient with COVID-19. appeared first on Links Medicus.
Cohort study: Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S. 11 excess venous thromboembolic events per 100 000 vaccinations; 2.5 excess cerebral venous thrombosis per 100 000 v
vendredi, 07 mai 2021 15:06 Écrit par Zouhair SouissiArterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study – The BMJ Editorial: Thromboembolism and the Oxford-AstraZeneca vaccine – The BMJ Commentaries: Thrombosis and bleeding after the Oxford-AstraZeneca covid-19 vaccination – The BMJ Opinion AND Putting risks into context: covid-19 vaccines and blood clots […]
The post Cohort study: Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S. 11 excess venous thromboembolic events per 100 000 vaccinations; 2.5 excess cerebral venous thrombosis per 100 000 vaccinations. appeared first on Links Medicus.
One third of patients hospitalized with COVID-19 have lung changes after a year
vendredi, 07 mai 2021 15:06 Écrit par Zouhair Souissi3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study – The Lancet Respiratory Medicine Commentaries: One third of patients hospitalized with COVID-19 have lung changes after a year – University of Southampton AND An integrated understanding of long-term sequelae after acute COVID-19 – The Lancet Respiratory Medicine
The post One third of patients hospitalized with COVID-19 have lung changes after a year appeared first on Links Medicus.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
vendredi, 07 mai 2021 15:06 Écrit par Zouhair SouissiNews release: COVID-19 has caused 6.9 million deaths globally, more than double what official reports show – Institute for Health Metrics and Evaluation Report: Estimation of total mortality due to COVID-19 – Institute for Health Metrics and Evaluation Commentaries: New analysis finds global Covid death toll is double official estimates – STAT AND Global COVID-19 […]
The post COVID-19 has caused 6.9 million deaths globally, more than double what official reports show appeared first on Links Medicus.
Opinion | Covid-19: Sputnik vaccine rockets, thanks to Lancet boost
vendredi, 07 mai 2021 10:34 Écrit par Zouhair SouissiCovid-19: Sputnik vaccine rockets, thanks to Lancet boost – The BMJ Commentary on Twitter Journals risk being used in place of regulators when they publish studies of novel vaccines that have not yet been authorised by a major regulator @DoctorChrisVT unpicks the story of the Sputnik V vaccine https://t.co/lYf7l0lXcy — The BMJ (@bmj_latest) May […]
The post Opinion | Covid-19: Sputnik vaccine rockets, thanks to Lancet boost appeared first on Links Medicus.
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
vendredi, 07 mai 2021 10:34 Écrit par Zouhair SouissiThe COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity – The Lancet Respiratory Medicine Commentary on Twitter We forget that covid-19 is a new disease, never having been seen until late 2019, w/ different features than any prior illness. A truly outstanding review today on its pathophysiology https://t.co/8gx2w8r1xf @LancetRespirMed @osuchm and […]
The post The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity appeared first on Links Medicus.
![[Press release – not published yet] Moderna announces positive initial booster data against SARS-CoV-2 variants of concern.](/media/k2/items/cache/dc52d5c5f54b7db2dfd2aae465dc6ccd_S.jpg)
[Press release – not published yet] Moderna announces positive initial booster data against SARS-CoV-2 variants of concern.
jeudi, 06 mai 2021 13:42 Écrit par Zouhair SouissiModerna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern – Moderna Commentary: We just got our first evidence that Moderna’s coronavirus booster shot works to fight variants – Insider Commentaries on Twitter Moderna announces that a single dose of their #COVID19 booster shot provides a strong immunologic response to the variant first […]
The post [Press release – not published yet] Moderna announces positive initial booster data against SARS-CoV-2 variants of concern. appeared first on Links Medicus.
Practice changing | A four-month rifapentine regiment with moxifloxacin is noninferior to the standard 6-month regimen in the treatment of tuberculosis.
jeudi, 06 mai 2021 13:42 Écrit par Zouhair SouissiFour-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis – New England Journal of Medicine Commentary: Four-month TB treatment matches six-month standard of care – Aidsmap
The post Practice changing | A four-month rifapentine regiment with moxifloxacin is noninferior to the standard 6-month regimen in the treatment of tuberculosis. appeared first on Links Medicus.
Organ transplant recipients remain vulnerable to Covid-19 even after second vaccine dose.
jeudi, 06 mai 2021 13:42 Écrit par Zouhair SouissiOrgan Transplant Recipients Remain Vulnerable to Covid-19 Even After Second Vaccine Dose – Johns Hopkins Medicine Original Study: Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients – JAMA
The post Organ transplant recipients remain vulnerable to Covid-19 even after second vaccine dose. appeared first on Links Medicus.
Cohort study shows inadequate antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients.
jeudi, 06 mai 2021 13:42 Écrit par Zouhair SouissiAntibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study – Clinical Microbiology and Infection Commentary on Twitter The studies of mRNA vax in people with transplants are getting bigger: still the same message. Some protection, but not enough. This time, 308 people with kidney transplants in Israel, BNT-Pfizer vaccine […]
The post Cohort study shows inadequate antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients. appeared first on Links Medicus.
